Position in JNJ
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$61,583,969
+$8,420,791 QoQ
Shares Held
251,939
-1.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
4.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SMITH CHAS P & ASSOCIATES PA CPAS holds $179,997,284 across 8 Drug Manufacturers - General names. JNJ ranks #1 (34.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
251,939 | $61,583,969 | |
| 2 | MRK |
Merck & Co., Inc.
|
367,523 | $44,209,341 | |
| 3 | AMGN |
Amgen Inc
|
118,985 | $41,864,872 | |
| 4 | NVO |
Novo Nordisk A S
|
801,586 | $29,458,285 | |
| 5 | LLY |
ELI LILLY & Co
|
1,254 | $1,153,391 | |
| 6 | ABBV |
AbbVie Inc.
|
4,249 | $924,115 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,023 | $425,944 | |
| 8 | PFE |
Pfizer Inc
|
13,439 | $377,367 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $61,583,969 | 251,939 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $53,163,178 | 256,889 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $29,517,751 | 159,194 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $39,635,111 | 259,477 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $42,015,729 | 253,351 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $35,240,133 | 243,674 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $42,007,572 | 259,210 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $38,326,806 | 262,225 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $38,268,375 | 241,914 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $37,190,170 | 237,273 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $37,229,545 | 239,034 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $34,156,707 | 206,360 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $31,474,765 | 203,063 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $35,393,770 | 200,361 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $32,543,762 | 199,215 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $34,641,254 | 195,151 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $34,426,750 | 194,249 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $32,804,554 | 191,761 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $30,333,737 | 187,825 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $30,169,330 | 183,133 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $29,527,942 | 179,665 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $28,104,133 | 178,575 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $26,369,774 | 177,121 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $25,231,834 | 179,420 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $24,133,427 | 184,042 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||